ARVN
Arvinas, Inc.
NASDAQ · Healthcare · Biotechnology · US
$9.35
+0.38%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 9.76x
Trailing multiples
Trailing twelve months
- P/E TTM
- 49.19x
- PEG TTM
- —
- Price / book
- 1.09x
- Price / sales
- 1.93x
- Price / cash flow
- -2.95x
Enterprise value
- Enterprise value
- $51.4M
- EV / sales
- 0.16x
- EV / EBITDA
- 17.71x
- EV / EBIT
- -3.64x
- Market cap
- $611.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026